In parallel efforts, we have recently used HEXA and HEXB KO lines to demonstrate the existence of the noncanonical truncation pathway in other cancer cells indicating that Hex-mediated paucimannosidic protein formation may be a biosynthetic pathway generally active across various cancer cell types (thus not unique to CRC) (53). This evidence concerns the gene HEXA and cancer.